Blueprint Medicines (BPMC) Reports Q1 Loss, Tops Revenue Estimates

Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024

Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024

Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024

Earnings Preview: Stoke Therapeutics, Inc. (STOK) Q1 Earnings Expected to Decline

Will Myriad Genetics (MYGN) Report Negative Q1 Earnings? What You Should Know

Will Myriad Genetics (MYGN) Report Negative Q1 Earnings? What You Should Know

Will Myriad Genetics (MYGN) Report Negative Q1 Earnings? What You Should Know

Nearly Half of Americans Say They've Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health Monitor

Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health Monitor

Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health Monitor

New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen

New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen

New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen

Atossa (ATOS) Reports Positive Results From EVANGELINE Study

Myriad Genetics (MYGN) Announces Favorable Research Results

Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now

Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight Testing

Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight Testing

Novavax (NVAX) Down 3.2% Since Last Earnings Report: Can It Rebound?